Nathan Green, MD
Urology · Pine Bluff, ARNPI 1457858508
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Coloplast at 35.9% of the total. Reporting peaked in 2024 at $3,173 and has fallen 56.6% since, to $1,376 in 2025.
Across 109 payments — averaging $62.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- Intuitive Surgical$2K
- Teleflex LLC$985
- Boston Scientific$544
- Axonics, Inc.$295
- AbbVie$244
- plus $784 from 12 others
What the payments were for
- Travel & lodging$1,39721%
- Food & beverage$3,88957%
- Education$1,50022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 41 | $2,434 |
| Intuitive Surgical | 1 | $1,500 |
| Teleflex LLC | 13 | $985 |
| Boston Scientific | 13 | $544 |
| Axonics, Inc. | 6 | $295 |
| AbbVie | 11 | $244 |
| Procept Biorobotics Corporation | 4 | $223 |
| Medtronic | 5 | $201 |
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Ambu Inc. | 1 | $35 |
| Photocure Inc | 2 | $31 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $30 |
| Angiodynamics, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- RESTORELLE$707
- ALTIS$579
- Barrigel$275
- UroLift$247
- AquaBeam Robotic System$163
- INTERSTIM$122
- Bulkamid$118
- Axonics$118
How this compares
$6,786 in reported general payments places this provider in the 55th percentile of 88 urology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 82 | $57,536 |
| MyrbetriqMirabegron | 23 | $12,281 |
| Estradiol | 55 | $3,808 |
| Tamsulosin Hcl | 134 | $1,209 |
| Trospium Chloride | 12 | $1,183 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $832 |
| Diclofenac Sodium | 47 | $251 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 46 | $204 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $192 |
| Finasteride | 18 | $160 |
| Ciprofloxacin Hcl | 21 | $107 |
| Levofloxacin | 15 | $52 |
| Oxycodone Hcl | 13 | $22 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $119 | $57,53682 claims |
| Astellas Pharma US IncMyrbetriq | $27 | $12,28123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 88 urology providers in Arkansas.
Other urology in Pine Bluff
- David JacksPine Bluff$125K
- David LupoPine Bluff$20K
- Dennis JacksPine Bluff$20K
- Jordan HanberryPine Bluff$17K
- Nickolas ScherzerPine Bluff$9K
- Donald MooneyLittle Rock$148K
- Timothy GoodsonLittle Rock$147K
- Ronald KuhnNorth Little Rock$138K
- Caleb BozemanLittle Rock$136K
- David CoussensLittle Rock$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.